AOD 9604 With Retatrutide: Evidence, Safety, and UK Regulatory Status AOD 9604 with retatrutide is a combination increasingly discussed in weight-loss and body-composition circles, yet neither compound holds a Marketing Authorisation from the MHRA or EMA for use in the UK
Further, it activates muscle stem cells, promoting tissue regeneration, and reverses insulin resistance in relevant animal models, all with good systemic tolerability 1,2
Food and Drug Administration (FDA) for medical use in humans
55.00 - AOD-9604 - Research Peptide AOD-9604 is a modified peptide fragment of human growth hormone (HGH), studied for its potential in fat metabolism and regenerative applications
The Nurse Clinic uses Prescription only B12 called Hydroxocobalamin 1mg/1ml
It is studied as an inhibitor of nicotinamide N-methyltransferase